AlhajHWisniewskiGMcAllister-WilliamsRH (2011) The use of the EEG in measuring therapeutic drug: action: focus on depression and antidepressants. J Psychopharmacol25: 1175–1191.
2.
BaresMBrunovskyMKopecekM. (2007) Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psych Res41: 319–325.
3.
BaresMBrunovskyMKopecekM. (2008) Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry23: 350–355.
4.
BaresMBrunovskyMNovakT. (2010) The change in prefrontal QEEG theta cordance predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressants treatment. Eur Neuropsychopharmacol20: 459–466.
5.
CookIALeuchterAFMorganM. (2002) Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology27: 120–131.
6.
HoracekJBrunovskyMNovakTB. (2010) Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect. Psychol Med40: 1443–1451.
7.
HunterAMCookIAGreenwaldS. (2011). The Antidepressant Treatment Response (ATR) index and treatment outcomes in a placebo-controlled trial of fluoxetine. Clin Neurophysiol, in press.
8.
HunterAMCookIALeuchterAF (2007). The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psych Clin N Am30: 105–124.
9.
IosifescuDVGreenwaldSDevlinP. (2009) Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol19: 772–777.
10.
KopecekMSosPBrunovskyM. (2007) Can prefrontal theta cordance differentiate between depression recovery and dissimulation?Neuro Endocrinol Lett28: 524–526.
11.
KopecekMTislerovaBSosP. (2008) QEEG changes during switch from depression to hypomania/mania: a case report. Neuro Endocrinol Lett29: 295–302.
12.
LeuchterAFCookIAGilmerWS. (2009a) Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res169: 132–138.
13.
LeuchterAFCookIALufkinR. (1994a) Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. NeuroImage1: 208–219.
14.
LeuchterAFCookIAMarangellLB. (2009b) Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of brite-md study. Psychiatry Res169: 124–131.
15.
LeuchterAFCookIAMenaI. (1994b) Assessment of cerebral perfusion using quantitative EEG cordance. Psych Res Neuroimaging55: 141–152.
16.
LeuchterAFUijtdehaageSHJCookIA. (1999) Relationship between brain electrical activity and cortical perfusion in normal subjects. Psych Res Neuroimaging90: 125–140.
